1. Home
  2. NYT vs QGEN Comparison

NYT vs QGEN Comparison

Compare NYT & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo New York Times Company (The)

NYT

New York Times Company (The)

N/A

Current Price

$72.85

Market Cap

10.1B

ML Signal

N/A

QGEN

Qiagen N.V.

N/A

Current Price

$49.86

Market Cap

9.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NYT
QGEN
Founded
1851
1986
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Newspapers/Magazines
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.1B
9.0B
IPO Year
1994
1998

Fundamental Metrics

Financial Performance
Metric
NYT
QGEN
Price
$72.85
$49.86
Analyst Decision
Buy
Hold
Analyst Count
10
12
Target Price
★ $77.00
$49.77
AVG Volume (30 Days)
2.3M
★ 5.9M
Earning Date
11-04-2026
11-04-2026
Dividend Yield
1.29%
★ 5.51%
EPS Growth
★ 18.08
N/A
EPS
★ 1.71
N/A
Revenue
★ $1,783,639,000.00
N/A
Revenue This Year
$11.23
$2.21
Revenue Next Year
$7.55
$5.11
P/E Ratio
$41.92
★ $24.01
Revenue Growth
N/A
★ N/A
52 Week Low
$58.87
$32.53
52 Week High
$87.10
$57.82

Technical Indicators

Market Signals
Indicator
NYT
QGEN
Relative Strength Index (RSI) 62.60 60.54
Support Level $72.59 $47.37
Resistance Level $74.60 $50.90
Average True Range (ATR) 2.41 0.25
MACD 0.38 -0.26
Stochastic Oscillator 92.87 0.00

Price Performance

Historical Comparison
NYT
QGEN

About NYT New York Times Company (The)

New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as NYTimes and various smartphone applications. The company derives revenue from subscriptions, advertising, and other sources, where the majority of its revenue is generated through subscriptions, which consist of income from standalone and multiproduct bundle subscriptions to its digital products and subscriptions to and single-copy and bulk sales of print products.

About QGEN Qiagen N.V.

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables, with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by Europe, the Middle East, and Africa (33%) and Asia-Pacific (15%).

Share on Social Networks: